Medicenna Therapeutics Corp. (TSE:MDNA - Get Free Report) shares hit a new 52-week low on Thursday . The stock traded as low as C$0.85 and last traded at C$0.90, with a volume of 42054 shares trading hands. The stock had previously closed at C$0.91.
Medicenna Therapeutics Price Performance
The stock has a market capitalization of C$65.09 million, a price-to-earnings ratio of -2.40 and a beta of 1.21. The company has a 50 day moving average of C$1.02 and a 200 day moving average of C$1.19. The company has a quick ratio of 4.65, a current ratio of 11.40 and a debt-to-equity ratio of 0.88.
Medicenna Therapeutics Company Profile
(
Get Free Report)
Medicenna Therapeutics Corp is a Canada based immuno-oncology company. Its principal business activity is the development and commercialization of Empowered Cytokines and Superkines for the treatment of cancer. The company is engaged in developing Interleukin-4 Empowered Cytokines that specifically target the Interleukin-4 Receptor which is over-expressed by 20 different cancers, cancer stem cells and immunosuppressive cells of the tumor microenvironment.
Recommended Stories
Before you consider Medicenna Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medicenna Therapeutics wasn't on the list.
While Medicenna Therapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
